Get a Quote!
Get A Quote!
CEO Jeffery Bacha Discusses DelMar’s VOL-083 Clinical Trials and the Major Milestones Ahead
CNA Finance Initiates Research Coverage On Advanced Medical Isotope Corporation
Premier Biomedical, Inc. CEO Letter – July, 2017
Phase 2 Trial of ProscaVax for Early-Stage Prostate Cancer Nears Commencement
Premier Biomedical Launches Volume Manufacture of Topical Pain Relief Products Enabling Significant Expansion of Business
Easton Pharmaceuticals Announces it has Received $400,000 USD in Product Purchase Orders for the Current Quarter from it’s Woman’s Diagnostic and Treatment Products Business for the Mexico Market
Pressure BioSciences Ramps Up Commercialization of Next-Generation Instrument with CE Marking — SECFilings.com
Medical Marijuana, Inc. Subsidiary HempMeds Mexico® Receives COFEPRIS Permission for Flagship Product RSHO-X™ Usage for Cancer Patient
Premier Biomedical’s Research on its Patent Pending Anti-Cancer Treatment With Metronomic Chemotherapy Recognized for Publication in the Prestigious British Journal of Cancer
OncBioMune Pharmaceuticals CEO, Dr. Jon Head, Updates Progress of their Prostate Cancer Vaccine
Premier Biomedical Anti-Cancer Antibody Outperforms Leading Multi-Billion Dollar Commercial Cancer Treatments in Initial Head-to-Head Testing at a Major University
Wally Klemp, with Moleculin Biotech, Inc. (MBRX), discusses on Uptick Network their new treatment for Second-Line Leukemia Patients